Cargando…

Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population

BACKGROUND: Perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) are persistent environmental contaminants that affect metabolic regulation, inflammation, and other factors implicated in the development and progression of colorectal cancer (CRC). However, the link between these compounds a...

Descripción completa

Detalles Bibliográficos
Autores principales: Innes, Kim E, Wimsatt, Jeffrey H, Frisbee, Stephanie, Ducatman, Alan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909456/
https://www.ncbi.nlm.nih.gov/pubmed/24468211
http://dx.doi.org/10.1186/1471-2407-14-45
_version_ 1782301858532950016
author Innes, Kim E
Wimsatt, Jeffrey H
Frisbee, Stephanie
Ducatman, Alan M
author_facet Innes, Kim E
Wimsatt, Jeffrey H
Frisbee, Stephanie
Ducatman, Alan M
author_sort Innes, Kim E
collection PubMed
description BACKGROUND: Perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) are persistent environmental contaminants that affect metabolic regulation, inflammation, and other factors implicated in the development and progression of colorectal cancer (CRC). However, the link between these compounds and CRC remains unknown. In this cross-sectional study, we investigated the association of CRC diagnosis to PFOA and PFOS blood levels in a large Appalachian population. METHODS: Participants were 47,359 adults ≥ 21 years of age and residing in six PFOA-contaminated water districts in the mid-Ohio Valley (N = 47,151 cancer-free adults, 208 cases of primary CRC). All participants completed a comprehensive health survey between 2005 and 2006; serum levels of PFOA, PFOS, and a range of other blood markers were also measured. Medical history was assessed via self report and cancer diagnosis confirmed via chart review. RESULTS: CRC showed a strong inverse, dose–response association with PFOS serum levels (odds ratio (OR) adjusted for potential confounders = 0.2, 95% confidence interval (CI) 0.2,0.3) for highest vs. lowest quartile of PFOS, P-trend < 0.00001) and a significant, but more modest inverse association with PFOA (adjusted OR = 0.6 (CI 0.4, 0.9) for highest vs. lowest quartile, P-trend = 0.001). These inverse associations were stronger in those diagnosed within the previous 6 years and resident in the same water district for a minimum of 10–15 years preceding assessment. The relationship between PFOA and CRC was also more pronounced in men and leaner adults, and showed a stronger linear trend at lower exposure levels. CONCLUSIONS: In this large cross-sectional study, we found a strong, inverse association between PFOS and likelihood of CRC diagnosis and a significant, although more modest inverse association between PFOA and CRC. If confirmed in prospective investigations, these findings may aid in identifying new strategies for CRC prevention and treatment and inform future studies regarding mechanisms underlying CRC pathogenesis.
format Online
Article
Text
id pubmed-3909456
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39094562014-02-02 Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population Innes, Kim E Wimsatt, Jeffrey H Frisbee, Stephanie Ducatman, Alan M BMC Cancer Research Article BACKGROUND: Perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) are persistent environmental contaminants that affect metabolic regulation, inflammation, and other factors implicated in the development and progression of colorectal cancer (CRC). However, the link between these compounds and CRC remains unknown. In this cross-sectional study, we investigated the association of CRC diagnosis to PFOA and PFOS blood levels in a large Appalachian population. METHODS: Participants were 47,359 adults ≥ 21 years of age and residing in six PFOA-contaminated water districts in the mid-Ohio Valley (N = 47,151 cancer-free adults, 208 cases of primary CRC). All participants completed a comprehensive health survey between 2005 and 2006; serum levels of PFOA, PFOS, and a range of other blood markers were also measured. Medical history was assessed via self report and cancer diagnosis confirmed via chart review. RESULTS: CRC showed a strong inverse, dose–response association with PFOS serum levels (odds ratio (OR) adjusted for potential confounders = 0.2, 95% confidence interval (CI) 0.2,0.3) for highest vs. lowest quartile of PFOS, P-trend < 0.00001) and a significant, but more modest inverse association with PFOA (adjusted OR = 0.6 (CI 0.4, 0.9) for highest vs. lowest quartile, P-trend = 0.001). These inverse associations were stronger in those diagnosed within the previous 6 years and resident in the same water district for a minimum of 10–15 years preceding assessment. The relationship between PFOA and CRC was also more pronounced in men and leaner adults, and showed a stronger linear trend at lower exposure levels. CONCLUSIONS: In this large cross-sectional study, we found a strong, inverse association between PFOS and likelihood of CRC diagnosis and a significant, although more modest inverse association between PFOA and CRC. If confirmed in prospective investigations, these findings may aid in identifying new strategies for CRC prevention and treatment and inform future studies regarding mechanisms underlying CRC pathogenesis. BioMed Central 2014-01-27 /pmc/articles/PMC3909456/ /pubmed/24468211 http://dx.doi.org/10.1186/1471-2407-14-45 Text en Copyright © 2014 Innes et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Innes, Kim E
Wimsatt, Jeffrey H
Frisbee, Stephanie
Ducatman, Alan M
Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population
title Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population
title_full Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population
title_fullStr Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population
title_full_unstemmed Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population
title_short Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population
title_sort inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (pfos) and perfluorooctanoate (pfoa) in a large appalachian population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909456/
https://www.ncbi.nlm.nih.gov/pubmed/24468211
http://dx.doi.org/10.1186/1471-2407-14-45
work_keys_str_mv AT inneskime inverseassociationofcolorectalcancerprevalencetoserumlevelsofperfluorooctanesulfonatepfosandperfluorooctanoatepfoainalargeappalachianpopulation
AT wimsattjeffreyh inverseassociationofcolorectalcancerprevalencetoserumlevelsofperfluorooctanesulfonatepfosandperfluorooctanoatepfoainalargeappalachianpopulation
AT frisbeestephanie inverseassociationofcolorectalcancerprevalencetoserumlevelsofperfluorooctanesulfonatepfosandperfluorooctanoatepfoainalargeappalachianpopulation
AT ducatmanalanm inverseassociationofcolorectalcancerprevalencetoserumlevelsofperfluorooctanesulfonatepfosandperfluorooctanoatepfoainalargeappalachianpopulation